I agree that this site is using cookies. You can find further informations here.
X
Lugtenburg, Pieternella
285  results:
Search for persons X
?
1

Treatment and outcomes for patients with relapsed or refrac..:

Pennings, Elise R. A. ; Durmaz, Müjde ; Visser, Otto...
Blood Cancer Journal.  14 (2024)  1 - p. , 2024
Link: https://doi.org/10.1038/..
 
?
2

Epcoritamab monotherapy in patients with relapsed or refrac..:

Linton, Kim M ; Vitolo, Umberto ; Jurczak, Wojciech...
The Lancet Haematology.  11 (2024)  8 - p. e593-e605 , 2024
Link: https://doi.org/10.1016/..
 
?
3

Deep and Durable Responses with Epcoritamab SC Monotherapy ..:

Linton, Kim M ; Jurczak, Wojciech ; Lugtenburg, Pieternella J....
Transplantation and Cellular Therapy.  30 (2024)  2 - p. S33-S34 , 2024
Link: https://doi.org/10.1016/..
 
?
4

Improvements in Patient-Reported Outcomes in Relapsed or Re..:

Phillips, Tycel ; Lugtenburg, Pieternella ; Kalsekar, Anupama...
Clinical Lymphoma Myeloma and Leukemia.  24 (2024)  3 - p. e78-e87.e2 , 2024
Link: https://doi.org/10.1016/..
 
?
5

High Complete Metabolic Response Rates with Epcoritamab SC ..:

Brody, Joshua ; Jørgensen, Judit ; Belada, David...
Transplantation and Cellular Therapy.  30 (2024)  2 - p. S357 , 2024
Link: https://doi.org/10.1016/..
 
?
6

P1139: COMPARISON OF 6XR-CHOP21 VERSUS 6XR-CHOP+2R FOR ADVA..:

Maas, Carolien ; van Klaveren, David ; Durmaz, Mujde...
HemaSphere.  7 (2023)  S3 - p. e80376cd , 2023
Link: https://doi.org/10.1097/..
 
?
7

IBCL-474 Epcoritamab + R2 Regimen and Responses in Patients..:

Merryman, Reid W. ; Belada, David ; Sureda, Anna...
Clinical Lymphoma Myeloma and Leukemia.  23 (2023)  - p. S454 , 2023
Link: https://doi.org/10.1016/..
 
?
8

POSTER: IBCL-474 Epcoritamab + R2 Regimen and Responses in ..:

Merryman, Reid W. ; Belada, David ; Sureda, Anna...
Clinical Lymphoma Myeloma and Leukemia.  23 (2023)  - p. S210 , 2023
Link: https://doi.org/10.1016/..
 
?
9

P1128: EVALUATION OF STANDARD OF CARE IN SECOND-LINE FOR PA..:

Pennings, Elise R.A. ; Durmaz, Müjde ; Visser, Otto...
HemaSphere.  7 (2023)  S3 - p. e992046d , 2023
Link: https://doi.org/10.1097/..
 
?
10

No sex differential in relative survival among older patien..:

Geerdes, Emma E. ; Durmaz, Müjde ; Lugtenburg, Pieternella J....
Blood Advances.  7 (2023)  17 - p. 4869-4873 , 2023
Link: https://doi.org/10.1182/..
 
?
11

The Dutch CAR-T Tumorboard Experience: Population-Based Rea..:

Spanjaart, Anne M. ; Pennings, Elise R. A. ; Mutsaers, Pim G. N. J....
Cancers.  15 (2023)  17 - p. 4334 , 2023
Link: https://doi.org/10.3390/..
 
?
12

Oral Abstract: ABCL-500 Longer Follow-Up Reaffirms Subcutan..:

Karimi, Yasmin ; Ghesquieres, Herve ; Jurczak, Wojciech...
Clinical Lymphoma Myeloma and Leukemia.  23 (2023)  - p. S147 , 2023
Link: https://doi.org/10.1016/..
 
?
13

POSTER: ABCL-500 Longer Follow-Up Reaffirms Subcutaneous Ep..:

Karimi, Yasmin ; Ghesquieres, Herve ; Jurczak, Wojciech...
Clinical Lymphoma Myeloma and Leukemia.  23 (2023)  - p. S203 , 2023
Link: https://doi.org/10.1016/..
 
?
14

Cellular therapy in lymphoma:

Sureda, Anna ; Lugtenburg, Pieternella J. ; Kersten, Marie José...
Hematological Oncology.  , 2023
Link: https://doi.org/10.1002/..
 
?
15

S222: EPCORITAMAB WITH RITUXIMAB + LENALIDOMIDE (R2) PROVID..:

Sureda, Anna ; Falchi, Lorenzo ; Leppa, Sirpa...
HemaSphere.  7 (2023)  S3 - p. e5547136 , 2023
Link: https://doi.org/10.1097/..
 
1-15